Profil
John Dadurian worked as a Senior Director of Finance and Accounting at Albireo Pharma, Inc. from 2018 to 2021.
Anciens postes connus de John Dadurian
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2021 |
Expériences
Fonctions occupées
Relations
6
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
